Research location
Cuernavaca
Morelos, Mexico
Advertisement
Research activity in Cuernavaca
Morelos, MexicoCureCurrent currently publishes aggregate city-level research activity for this location: 84 trials and 85 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Cuernavaca
84 linked trials · page 1 of 2A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesNCT07351058 · 2026-03-23 · 1 site observation
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesNCT07351045 · 2026-03-16 · 1 site observation
RECRUITING
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation
RECRUITING
Multidimensional Intervention in Mexican SchoolchildrenNCT07185789 · 2023-11-07 · 1 site observation
RECRUITING
PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American WomenNCT03144648 · 2012-10-12 · 1 site observation
RECRUITING
Effect of Tocopherol and Ascorbic Acid on Neuroinflammation Markers Associated With Neuropeptide Expression in the AgRP/NPY and POMC Pathways in Mexican Population With ObesityNCT07782411 · 2026-08-10 · 1 site observation
NOT_YET_RECRUITING
Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)NCT06651957 · 2024-10-31 · 1 site observation
ACTIVE_NOT_RECRUITING
Pilot Trial of Hibiscus Drink During Pregnancy (PTHDDP)NCT07175597 · 2024-04-30 · 1 site observation
COMPLETED
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)NCT06260722 · 2024-02-21 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With MetforminNCT06192108 · 2024-01-10 · 1 site observation
COMPLETED
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American CountriesNCT06002126 · 2023-08-02 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or OverweightNCT05929066 · 2023-07-10 · 1 site observation
COMPLETED
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)NCT05662332 · 2023-01-14 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)NCT05564039 · 2022-11-30 · 1 site observation
COMPLETED
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIVNCT04255849 · 2021-02-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)NCT04701983 · 2020-12-16 · 1 site observation
COMPLETED
Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and AboveNCT04526990 · 2020-09-15 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesNCT04255433 · 2020-05-29 · 1 site observation
COMPLETED
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid ArthritisNCT04186871 · 2020-01-07 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) in Participants With Obesity or OverweightNCT04184622 · 2019-12-04 · 1 site observation
COMPLETED
An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 DiabetesNCT03811288 · 2018-12-10 · 1 site observation
COMPLETED
Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe AsthmaNCT03207243 · 2017-09-14 · 1 site observation
COMPLETED
Effect of the CAIPaDi Care Model in Relatives of Patients With Type 2 Diabetes MellitusNCT03234946 · 2017-06-19 · 1 site observation
UNKNOWN
Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 DiabetesNCT03136484 · 2017-03-15 · 1 site observation
COMPLETED
Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate CancerNCT02799602 · 2016-11-30 · 1 site observation
COMPLETED
A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350NCT02983227 · 2016-11-30 · 1 site observation
COMPLETED
Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To MethotrexateNCT02996500 · 2016-11-10 · 1 site observation
COMPLETED
Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid ArthritisNCT02919761 · 2016-11-07 · 1 site observation
COMPLETED
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)NCT02833350 · 2016-09-09 · 1 site observation
COMPLETED
A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes MellitusNCT02501161 · 2016-01-31 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseNCT02540993 · 2015-09-17 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseNCT02545049 · 2015-09-17 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid ArthritisNCT02504671 · 2015-07-23 · 2 site observations
COMPLETED
Metabolic Syndrome Diagnosis and Treatment for Adults of Low Socioeconomic Status CommunitiesNCT02459249 · 2015-04-01 · 1 site observation
UNKNOWN
Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infectionNCT02178592 · 2015-01-23 · 1 site observation
COMPLETED
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast CancerNCT02246621 · 2014-11-06 · 1 site observation
ACTIVE_NOT_RECRUITING
A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further IntensificationNCT02100475 · 2014-04-01 · 1 site observation
COMPLETED
Effect of Two Diets With Different Content of Protein on Weight Loss in Adults With Metabolic SyndromeNCT02278757 · 2014-01-01 · 1 site observation
COMPLETED
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular EventsNCT01959529 · 2013-10-29 · 1 site observation
COMPLETED
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes MellitusNCT01952145 · 2013-09-20 · 1 site observation
COMPLETED
Glycemic Index and Insulinemic Index of 3 Types of Tortilla in Mexican AdultsNCT02294123 · 2013-09-01 · 1 site observation
COMPLETED
Effectiveness of Physical Activity Prescription Among Hypertensive Patients of Primary Health Care.NCT01910935 · 2013-07-01 · 1 site observation
COMPLETED
Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 DiabetesNCT01720446 · 2013-02-21 · 1 site observation
COMPLETED
Evaluation of an Intervention Based on Cell PhonesNCT02094846 · 2012-10-01 · 1 site observation
COMPLETED
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation
TERMINATED
VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes MellitusNCT01528254 · 2012-03-30 · 1 site observation
COMPLETED
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 DiabetesNCT01481116 · 2012-01-01 · 1 site observation
TERMINATED
A Child Care-based Obesity Prevention InterventionNCT01679938 · 2011-05-01 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 1 site observation
COMPLETED
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes MellitusNCT01007097 · 2009-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.